Bienes Cambio Fecha
AbbVie USD 147.68B 12.57B 2026-09
Alaunos Therapeutics USD 1.52M 367K 2026-06
Amgen USD 96.05B 409M 2026-09
Ardelyx USD 587.52M 11.63M 2026-09
Arrowhead Research USD 1.74B 373.76M 2026-09
Bayer EUR 113.47B 6.18B 2026-09
Biogen USD 32.05B 32.5M 2026-09
Corcept Therapeutics USD 1.03B 145.32M 2026-09
Curis USD 29.69M 9.72M 2026-03
Gilead Sciences USD 51.41B 2.05B 2026-09
J&J USD 197.42B 3.64B 2026-09
Karyopharm Therapeutics USD 131.42M 23M 2026-03
Novartis USD 117.15B 4.88B 2026-09
Novavax USD 888M 67.57M 2026-09
PTC Therapeutics USD 3.21B 42.76M 2026-09
Puma Biotechnology USD 202.86M 7.95M 2025-09
Regeneron Pharmaceuticals USD 44.41B 2.67B 2026-09
Roche Holding CHF 98.2B 2.5B 2026-06
TG Therapeutics USD 1.59B 47.38M 2026-09
Verastem USD 227.81M 18.63M 2026-03
Vertex Pharmaceuticals USD 32.74B 5.31B 2026-09